Kinga Matuła is the CEO and co-founder of QurieGen. With over thirteen years of experience in research at the intersection of chemistry, biology, and physics, Kinga is passionate about turning scientific discoveries into tangible impacts. As a former oncological patient,  trained in venture investment (Women2Invest Supernova Program), she is deeply committed to bridging the gap between innovation and patients. Kinga has received startup business development training from various programs, including the Silicon Valley Draper Hero Program. Under her leadership, QurieGen won the Venture Challenge (May 2022) and received a Golden Ticket to Silicon Valley's prestigious 5-week accelerator program (July 2022), placing 2nd in Demo Day led by Tim Draper (selected out of 55 companies from 27 countries) and achieved recognition as the 2nd Award Winner in the FEM-START competition, winning an exciting journey to Silicon Valley to connect with investors, the ScaleNL team, and immerse into the top tech startup ecosystem.